Abeona Therapeutics to Present at Stifel Virtual Cell Therapy Forum

July 8, 2024 – Abeona Therapeutics (Nasdaq: ABEO) has revealed that its Chief Executive Officer, Dr. Vish Seshadri, and Chief Commercial Officer, Dr. Madhav Vasanthavada, will engage in a virtual fireside chat at the upcoming Stifel Virtual Cell Therapy Forum. The event is scheduled for Tuesday, July 9, 2024, at 9:45 a.m. Eastern Time. Those interested can watch a live webcast of the session on the Investors section of the Abeona website under "Events." The webcast will remain accessible for 30 days following the event.

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical firm focusing on the development of cell and gene therapies aimed at treating severe diseases. One of their major projects includes prademagene zamikeracel (pz-cel), an investigational autologous COL7A1 gene-corrected epidermal sheet designed for treating recessive dystrophic epidermolysis bullosa. This condition is a significant focus due to its severity and the high unmet medical needs of patients suffering from it.

Abeona has developed a fully integrated cell and gene therapy cGMP manufacturing facility, which has served as the production site for pz-cel utilized in its Phase 3 VIITAL™ trial. This facility is also capable of supporting the commercial production of pz-cel upon receiving FDA approval. The company's development portfolio extends beyond dermatological conditions to include AAV-based gene therapies for ophthalmic diseases, which also present a high unmet medical need.

In addition to the above, Abeona's innovative, next-generation AAV capsids are under evaluation. These capsids aim to enhance tropism profiles, which could lead to better targeting and effectiveness for a variety of devastating diseases.

Abeona Therapeutics continues to position itself at the forefront of cell and gene therapy research and development. The upcoming participation of Dr. Seshadri and Dr. Vasanthavada in the Stifel Virtual Cell Therapy Forum is expected to provide valuable insights into the company's ongoing projects and strategic vision.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!